ABSTRACT
T
he Hepacivirus genus of the Flaviviridae family was originally created to uniquely classify hepatitis C virus (HCV), a virus that chronically infects an estimated 130 million to 170 million individuals worldwide. Until recently, only one other virus was tentatively classified along with HCV within the Hepacivirus genus, GB virus B (GBV-B), a virus of unknown origin identified in 1995 in experimentally infected small New World primates (1) . GBV-B infects tamarins (Saguinus species) and marmosets (Callithrix species) and generally causes acute self-resolving hepatitis (2-4) but in some cases also causes protracted or chronic infections (5-7), making GBV-B an attractive surrogate animal model for HCV infection. In the past 3 years, several hepaciviral homologues have been identified in various mammalian species, including horses (8) (9) (10) , rodents (11, 12) , bats (13) , and Old World monkeys (14) . Based on phylogenetic relationships, these recently identified viruses were tentatively classified within the Hepacivirus genus. Although none of these new viruses has been conclusively identified as being hepatotropic, they represent valuable models to decipher conserved salient features of the hepacivirus life cycle and hepacivirus-host interactions and may guide future efforts in establishing useful surrogate rodent models.
The HCV genome encodes a polyprotein precursor that is cleaved co-and posttranslationally by cellular and viral proteases to yield the capsid protein (C) and two envelope glycoproteins (E1 and E2) that form the viral particle as well as seven nonstructural proteins (15) . GBV-B shares with HCV a common genomic organization, including a 5= nontranslated region (5= NTR) containing an internal ribosome entry site (16) (17) (18) (19) and conserved key enzymatic functions such as NS3-4A serine protease and helicase activities as well as NS5B RNA-dependent RNA polymerase activity (20) (21) (22) . Mechanisms of capsid protein maturation and lipid droplet targeting involved in particle morphogenesis (23) (24) (25) as well as the role of NS3-4A protease in disrupting host innate immune responses through the cleavage of the adaptor protein MAVS (26, 27) are also shared by GBV-B and HCV. Although experimental studies with the newly identified hepaciviruses are not as extensive, it has been reported that equine and some rodent hepacivirus genomes bear 5=-NTR organizations (8, 11) and the ability to cleave MAVS (28) similarly to HCV and GBV-B. Among nonstructural proteins, NS3 to NS5B were shown to be necessary and sufficient to ensure genome replication by establishing autonomously replicating subgenomic HCV and GBV-B RNAs (26, 29, 30) , and the small ion channel protein p7 as well as NS2 of HCV were found to be essential for particle morphogenesis (31) (32) (33) . HCV NS2 is a 217-amino-acid (aa) transmembrane (TM) protein that associates with the endoplasmic reticulum (ER) membrane of infected hepatoma cells (34, 35) . The p7/NS2 junction is cleaved by host signal peptidases, indicating that the NS2 N terminus resides in the ER lumen. A recently proposed topological model of HCV NS2 described three putative TM segments located within its N-terminal region (34) and a C-terminal globular cytosolic domain. The HCV NS2 C-terminal subdomain carries cysteine protease activity responsible for cleavage at the NS2/NS3 junction (36, 37) , and its crystal structure indicates that the NS2 protease is active as a dimer with composite active sites (38) . Moreover, efficient processing at the NS2/NS3 junction requires the NS3 N-terminal protease domain that acts as a cofactor (39) . In addition to its proteolytic activity, NS2 is involved in virion assembly and egress, although its precise mechanisms of action in these processes remain elusive. Several studies suggested that particle assembly could take place in specialized microdomains of the ER membrane, close to lipid droplets and replication sites (40, 41) , and requires the concerted action of structural but also nonstructural proteins that may be coordinated by NS2 (34, 35, (42) (43) (44) (45) .
In order to gain further insight into the mechanisms of action of NS2 during the HCV life cycle, we investigated whether NS2 structural and functional features are conserved among distantly related hepaciviruses such as GBV-B and HCV. In this study, analysis of the proteolytic processing of GBV-B NS2-NS3 precursors in transiently transfected cells revealed that GBV-B NS2 is also a cysteine protease responsible for the cleavage of the polyprotein at the NS2/NS3 junction, which we experimentally mapped between Thr 940 and Ala 941 of the viral polyprotein. GBV-B and HCV NS2 membrane topologies were comparatively studied through analyses of the membrane association properties of GBV-B NS2 segments and comparison with the proposed HCV NS2 topological model (31, 34) , determinations of GBV-B and HCV NS2 segment orientations with respect to the ER membrane using an N-glycosylation acceptor site tagging approach, as well as determinations of nuclear magnetic resonance (NMR) structures of selected GBV-B NS2 membrane binding segments. Overall, our data demonstrated that GBV-B and HCV NS2 proteins share similar topological organizations in spite of limited amino acid conservation. Based on these data, we investigated whether the mechanisms of action of NS2 during morphogenesis were conserved between GBV-B and HCV and across HCV genotypes by using a trans-complementation approach.
GB-NS2-3pro-ST and pCMV/JFH1-NS2-3pro-ST containing point substitutions of Cys177 (TGT) and Cys184 (TGT) codons into Ala (GCC) codons within GBV-B and HCV JFH1 NS2 protease catalytic sites, respectively (numbering refers to amino acid positions within NS2), were also generated by primer-based mutagenesis, yielding plasmids pCMV/GB-NS2(C177A)-3pro-ST and pCMV/JFH1-NS2(C184A)-3pro-ST.
Plasmid pJad was derived from pJFH1 to include cDNA substitutions resulting in three amino acid changes in the HCV polyprotein (Val2153Ala, Val2440Leu, and Val2941Met) that have been shown to increase viral production in cell culture (51) . Mutated sequences were derived from an NsiI-EcoRV restriction fragment of pJFH1-2EI3-adapt, kindly provided by R. Bartenschlager (University of Heidelberg, Heidelberg, Germany). Primer-based mutagenesis and overlapping PCR were used to replace the NotI-AvrII restriction fragment of pJad by a corresponding fragment containing an engineered mutation of the Ser168 (AGT) codon within NS2 into a Glu codon (GAA), resulting in pJad/ S168E.
Plasmids pHelper/NS2 JFH1 , -/NS2 J6 , -/NS2 N , and -/NS2 GB were generated by replacing the BglII-SwaI restriction fragment of plasmid pFK_i341helperSpNS2(Jc1) (31) , kindly provided by R. Bartenschlager, by nucleotide sequences encoding the C-terminal residues of p7/p13 acting as signal peptides and full-length NS2 amplified from HCV 2a-JFH1, HCV 2a-J6, HCV 1b-N, and GBV-B viral cDNAs and framed by BglII and SwaI engineered restriction sites. Plasmid pHelper/E2p7NS2 JFH1 was similarly constructed by amplifying 2a-JFH1 nucleotide sequences encoding the C-terminal residues of E1 acting as a signal peptide and E2-p7-NS2. Plasmids encoding chimeric NS2, pHelper/E2p7NS2-TM (123)-MA  J6 ,  -TM(123)-MA  N , -TM(123)  J6 , -TM(123)  N , -TM(1)  J6 , -TM(1)  N , and  -TM(1) GB , were generated by using overlapping PCR and the same strategy for insertion between the BglII and SwaI restriction sites. The sequences of all primers used and further details of these cloning procedures will be provided upon request. PCR-amplified DNA fragments from selected plasmid clones were analyzed by automated nucleotide sequencing using capillary electrophoresis (Applied Biosystems).
Sequence analyses and structure predictions. Sequence analyses were performed by using the Network Protein Sequence Analysis (NPSA) website (http://npsa-pbil.ibcp.fr/) (52) and the European HCV Database (53) . Multiple-sequence alignments and calculations of amino acid identities and similarities were performed with Clustal W (54). Protein secondary structures were deduced from a large set of prediction methods available at the NPSA website, including DSC, HNNC, MLRC, PHD, Predator, and SOPM. Various methods were combined for the prediction of TM segments, including DAS, HMMTOP, SOSUI, TMHMM, Tmpred, TOPPRED, and PHD-TM (available at the Expasy website [http://www .expasy.org/proteomics]). Interfacial hydrophobicity plots were generated with the MPEx program, which uses whole-residue hydrophobicity scales for hydropathy analysis of membrane proteins (http://blanco .biomol.uci.edu/mpex/). These hydrophobicity scales were determined experimentally by measuring the partitioning of host-guest peptides into bilayer interfaces and n-octanol (55) . The MPEx algorithm was demonstrated to accurately predict the TM segments of membrane proteins of known structure (56) .
Peptide synthesis and purification. GBV-B NS2(2-32), NS2 , and NS2(113-137) peptides, containing aa 2 to 32, 32 to 57, and 113 to 137 of GBV-B NS2, respectively, were synthesized on a Milligen 9050 apparatus, employing Fmoc (N-[9-fluorenyl]methoxycarbonyl) chemistry. The peptides were highly purified by reversed-phase high-performance liquid chromatography on a Nucleosil C 18 column (120 Å; 5 m) using a wateracetonitrile gradient containing 0.1% trifluoroacetic acid. The peaks were identified by mass spectroscopy as the peptides with the respective expected molecular masses. Circular dichroism. Far-UV circular dichroism (CD) spectra were recorded on a Chirascan spectrometer (Applied Photophysics) calibrated with 1S-(ϩ)-10-camphorsulfonic acid. Measurements were carried out at 25°C in a 0.1-cm-path-length quartz cuvette. Spectra were measured at a wavelength range of 180 to 260 nm with increments of 0.2 nm, a band pass of 0.5 nm, and an integration time of 1 s. Spectra were processed, baseline corrected, smoothed, and converted with Chirascan software. Spectral units were expressed as the mean molar ellipticity per residue by using the peptide concentrations determined by measuring the UV light absorbance of tyrosine and tryptophan at 280 nm. Estimation of the secondarystructure content was carried out with the DICHROWEB server (http: //dichroweb.cryst.bbk.ac.uk/) (57) .
Nuclear magnetic resonance spectroscopy. The purified GBV-B peptides were dissolved in a mixture of 50% (vol/vol) 2,2,2-trifluoroethanold 2 (TFE-d 2 ) (Ͼ99%) in H 2 O, and 2,2-dimethyl-2-silapentane-5-sulfonate was added to the NMR samples as an internal 1 H chemical shift reference. Multidimensional experiments were performed at 25°C on a Bruker Avance 500-MHz spectrometer using standard homonuclear pulse sequences, including nuclear Overhauser enhancement (NOE) spectroscopy (NOESY) (mixing times of between 100 and 250 ms) and clean total correlation spectroscopy (TOCSY) (isotropic mixing time of 80 ms), as detailed previously (58, 59 (60) .
NMR-derived constraints and structure calculation. NOE intensities used as the input for structure calculations were obtained from the NOESY spectrum recorded with a 150-ms mixing time and checked for spin diffusion on spectra recorded at lower mixing times (100 ms). NOEs were partitioned into three categories of intensities that were converted into distances ranging from a common lower limit of 1.8 Å to upper limits of 2.8 Å, 3.9 Å, and 5.0 Å, respectively. Protons without stereospecific assignments were treated as pseudoatoms, and the correction factors were added to the upper distance constraints (61) . No hydrogen bond or dihedral angle constraints were introduced. Three-dimensional structures were generated from NOE distances with the standard torsion angle molecular dynamics protocol in the X-plor-NIH 2.30 program (62), using standard force fields and default parameter sets. A set of 50 structures was initially calculated to widely sample the conformational space, and the structures of low energy with no distance restraint violations were retained. The selected structures were compared by pairwise root mean square deviation (RMSD) over the backbone atom coordinates (N, C ␣ , and C=). Statistical analyses, superimposition of structures, and structural analyses were performed with MOLMOL (63) , and the quality of the selected structures was checked with the Protein Data Bank (PDB) validation server.
Cell lines. Cos-1 cells were cultured in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal calf serum, 100 U/ml penicillin, and 100 g/ml streptomycin (DMEM-10%) at 37°C in a 5% CO 2 environment. Huh-7.5 human hepatocellular carcinoma cells (64) , kindly provided by C. Rice, were cultured in DMEM-10% supplemented with nonessential amino acids and 1 mM sodium pyruvate (complete DMEM).
Antibodies. Monoclonal antibodies specific for HCV core protein (Hep C HBcAg 1851) and HCV NS3 (clone 2E3) were purchased from Santa Cruz Biotechnology and BioFront Technologies, respectively. NS2-1519 rabbit polyclonal antibodies raised against HCV JFH1 NS2 synthetic peptides (31) were kindly provided by R. Bartenschlager. Monoclonal antibodies specific for GFP (JL-8), the V5 epitope, the Strep-tag epitope, p63 (G1/296), and GM130 (clone 35) were purchased from Clontech, Invitrogen, Qiagen, Enzo Life Sciences, and BD Biosciences, respectively.
DNA transfection. Cos-1 cells were seeded at a concentration of 2 ϫ 10 4 cells per well into 24-well plates and transfected 24 h later with 0.4 g of plasmid DNA by using FuGENE 6 transfection reagent (Promega), as recommended by the manufacturer.
In vitro transcription. Genome-length JFH1-based plasmids were linearized with XbaI and treated with mung bean nuclease (New England BioLabs), while plasmids containing helper subgenomic cDNAs were linearized with MluI. Linearized DNAs served as the templates for in vitro transcription using a T7 RiboMAX Express Large Scale RNA production system (Promega) according to the manufacturer's instructions. Synthetic RNAs were then purified by phenol-chloroform extractions and precipitated with isopropanol. RNA quality and quantity were monitored following 1% agarose gel electrophoresis and measurement of the absorbance at 260 nm.
RNA transfection. Huh-7.5 cells (2 ϫ 10 6 cells in 0.4 ml Opti-MEM [Life Technologies]) were transfected by electroporation with 5 g of in vitro-transcribed genome-length RNA or cotransfected with 5 g of genome-length RNA and 1.6 to 1.8 g of helper subgenomic RNA. Cells were electroporated in 4-mm-gap-width cuvettes by applying one pulse at 240 V at 900 F (EasyjecT Plus; Equibio) and then immediately resuspended in complete DMEM and seeded at 6 ϫ 10 5 cells per well in 6-well plates.
HCV TCID 50 titration. Huh-7.5 cells were seeded at a concentration of 4 ϫ 10 3 cells per well in 96-well plates and infected 24 h later with serial dilutions of transfected-cell supernatants harvested at 48 h posttransfection. After a 3-to 4-day incubation at 37°C, cells were fixed with methanol and incubated with phosphate-buffered saline (PBS) containing 0.3% (vol/vol) H 2 O 2 for 5 min at room temperature. Cells were then blocked for 30 min in 2.5% horse serum, and HCV antigen-expressing cells were detected following 1 h of incubation in PBS containing 0.1% Tween (PBS-T) and anti-NS3 monoclonal antibody at a final concentration of 0.3 g/ml. Bound anti-NS3 antibody was detected by a 30-min incubation with peroxidase-conjugated antibodies specific for murine IgG (ImmPRESS; Vector Laboratories) diluted 1:2 in PBS-T. Peroxidase activity was detected by using the liquid DABϩ substrate chromogen system (Dako). Viral titers (50% tissue culture infectious doses [TCID 50 ]/ml) were calculated according to the method of Reed and Muench (65) .
Immunoblot analysis. RNA-and DNA-transfected cells were lysed at 48 h and 32 to 40 h posttransfection, respectively, in NuPAGE LDS sample buffer (Life Technologies) containing 0.71 M 2-mercaptoethanol and heated for 10 min at 95°C. Proteins were loaded onto NuPAGE 10% or 12% Bis-Tris gels (Life Technologies), separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in morpholinepropanesulfonic acid (MOPS) SDS running buffer (Life Technologies), and transferred onto polyvinylidene difluoride (PVDF) membranes (GE Healthcare). Membranes were saturated in PBS-T containing 5% dry skimmed milk at room temperature for 1 h, prior to incubation for 1 h at room temperature or overnight at 4°C with one of the following monoclonal antibodies or antisera diluted in PBS-T containing 1% dry skimmed milk: anti-C (0.1 g/ml), anti-NS2 JFH1 (1:1,000), anti-V5 (1: 4,000), anti-Strep-tag (0.05 g/ml), anti-GFP (0.125 g/ml), or anti-p63 (0.5 g/ml). Following incubation for 1 h at room temperature with peroxidase-conjugated anti-mouse or anti-rabbit antibodies, proteins were visualized by using ECL Prime Western blotting detection reagent followed by exposure to Hyperfilm MP (all reagents were from GE Healthcare).
Immunofluorescence. Cos-1 cells grown on glass coverslips and transfected with pCMV-KEB-GFP-derived plasmid DNAs were fixed at 40 h posttransfection with 4% paraformaldehyde. Cells were permeabilized with 0.2% Triton X-100 and incubated for 15 min with 5% donkey and fetal calf sera and then for 1 h at room temperature with antibodies specific for p63 (1 g/ml) or GM130 (1.25 g/ml) diluted in PBS containing 1% donkey and fetal calf sera. Bound primary antibodies were revealed with Alexa Fluor 555 donkey anti-murine Ig antibody (Life Technologies). Coverslips were mounted in ProLong Gold Antifade reagent with 4=,6-diamidino-2-phenylindole (DAPI) (Life Technologies) and examined by using a fluorescence microscope with a 40ϫ oil immersion objective and an ApoTome optical sectioning device (Zeiss).
Membrane flotation assays. At 40 h posttransfection, DNA-transfected Cos-1 cells were subjected to Dounce homogenization in hypotonic lysis buffer (20 mM HEPES [pH 7], 100 mM NaCl) containing Complete protease inhibitor cocktail (Roche), followed by centrifugation at 1,000 ϫ g for 5 min to pellet nuclei, unlysed cells, and large debris. In control experiments (membrane fragmentation), Triton X-100 was added to postnuclear supernatants to a final concentration of 1%. Sucrose was added to postnuclear supernatants to a final concentration of 54% (wt/wt) in lysis buffer. The sucrose-containing lysate (0.5 ml) was overlaid with 2 ml of lysis buffer containing 45% sucrose (wt/wt) and 1.2 ml of lysis buffer in an open-top thick-wall polycarbonate tube (Beckman Coulter). Equilibrium centrifugation was carried out at 285,000 ϫ g for 100 min at 4°C in an SW55 Ti rotor (Beckman Coulter). Subsequently, 1 fraction of 1 ml, 1 fraction of 0.5 ml, and 5 fractions of 0.44 ml were collected from the top of the gradient, and equal volumes of each fraction were subjected to immunoblot analysis.
Glycosylation assays. At 32 h posttransfection, Cos-1 cells were lysed in glycoprotein denaturing buffer (0.5% SDS, 40 mM dithiothreitol [DTT]), heated for 10 min at 100°C, and incubated for 1 h at 37°C in the absence or in the presence of peptide-N-glycosidase F (PNGase F) (New England BioLabs) according to the manufacturer's instructions. Reaction mixtures were then supplemented with NuPAGE LDS sample buffer containing 2-mercaptoethanol to a final concentration of 0.71 M, heated for 3 min at 100°C, and sonicated for 10 s, and proteins were analyzed by immunoblotting.
Accession numbers. The atomic coordinates for the NMR structure of GBV-B NS2(2-32), NS2 , and NS2(113-137) and the corresponding NMR restraints in 50% TFE are available in the RCSB PDB under accession numbers 2LZP (RCSB identification code 103026), 2LZQ (RCSB identification code 103027), and 2MKB (RCSB identification code 103716), respectively. The chemical shifts of all peptide residues have been deposited in BioMagResBank (BMRB) under accession numbers 18768, 18769, and 19765, respectively. Viral strains considered in this study and the respective GenBank accession numbers (in parentheses) are as follows: bat hepacivirus (BHV) PDB-112 (KC796077), BHV PDB-452 (KC796090), BHV PDB-829 (KC796074), GBV-B (AY243572), Guereza hepacivirus 1 (GHV-1) BWC08 (KC551800), GHV-2 BWC04 (KC551802), HCV 1a-H77 (NC_004102), HCV 1b-Con1 (AJ238799), HCV 1b-N (AF139594), HCV 2a-JFH1 (AB047639), HCV 2a-J6 (D00944), HCV 2b-MD2b-1 (AF238486), HCV 3a-CB (AF046866), HCV 3b-TrKj (D49374), HCV 4a-ED43 (NC_009825), HCV 5a-SA13 (AF064490), HCV 6a-EUHK (Y12083), HCV 6b-Th580 (NC_009827), HCV 7a-QC69 (EF108306), nonprimate/equine hepacivirus (NPHV) B10-022 (JQ434004), NPHV EF369/11 (JX948116), NPHV G1-073 (JQ434002), NPHV NZP-1 (JQ434001), rodent hepacivirus (RHV) RHV-339 (KC815310), RHV NLR07-oct70 (KC411784), RHV RMU10-3382 (KC411777), and RHV SAR-46 (KC411807).
RESULTS
Predictions of GBV-B NS2 secondary structure. Based on sequence alignments between GBV-B and HCV polyproteins (17), GBV-B NS2 is predicted to comprise 208 aa residues, while HCV NS2 comprises 217 aa. The GBV-B NS2 amino acid sequence shares limited similarity with its HCV counterpart, e.g., approximately 21% amino acid identity (50 and 54% amino acid similarities) with HCV Con1 (genotype 1b) and JFH1 (genotype 2a) NS2 proteins, respectively (Fig. 1) . A greater degree of amino acid identity (29%) is found in the C-terminal one-third of NS2 from these two hepaciviruses, including conservation of His, Glu, and Cys residues that compose the catalytic triad of the HCV NS2 cysteine protease (at positions 143, 163, and 184, respectively) ( Fig. 1) . In addition, a Pro residue with a cis conformation at position 164 of HCV NS2, which is conserved in all HCV sequences and suspected to have a critical role in establishing the correct geometry of the Glu 163 side chain for catalysis (38) , is also conserved in GBV-B NS2 (Fig. 1) . By using various secondary-structure and TM segment prediction algorithms as well the MPEx algorithm, which calculates the likelihood of an amino acid insertion within an apolar environment (see Materials and Methods), five segments of GBV-B NS2 were predicted to exhibit propensity to partition into the membrane bilayer. These include three segments with predicted TM helical passages (aa 4 to 27, 71 to 93, and 116 to 135) and two segments with potential peripheral membrane association properties (aa 33 to 47 and 99 to 109). Only two predicted TM segments would thus be located in the GBV-B N-terminal domain, while three TM segments have been identified in the N-terminal domain of HCV Con1 NS2 by subcellular localization of GFP fusion proteins and NMR analysis of corresponding peptide structures (31, 34) . These bear roughly equivalent positions to the TM1 and TM3 segments in the HCV NS2 topological model, whereas no TM segment equivalent to HCV NS2 TM2 was predicted in GBV-B NS2 by most algorithms except partially by MPEx (Fig. 1) . Surprisingly, the third TM segment in GBV-B NS2 was predicted to lie in the C-terminal half of the protein (Fig. 1) , in a region homologous to the cytosolic protease domain of HCV NS2, whose structure was solved by X-ray crystallography (38) . Several complementary experimental approaches were undertaken in this study to assess putative membrane association and membrane-spanning properties of the five GBV-B NS2 segments predicted to be membranotropic by these algorithms.
GBV-B NS2 is an autoprotease. The GBV-B NS2 N-terminal boundary was previously experimentally determined by protein sequencing as the Phe 733 residue of the viral polyprotein (16), whereas its C terminus was only putatively predicted based on sequence alignments between GBV-B and HCV polyproteins. The experimental determination of the GBV-B NS2 C-terminal boundary and the identification of the protease responsible for NS2/NS3 cleavage were therefore important prerequisites for the study of GBV-B NS2 topology. In order to investigate whether GBV-B NS2 also exhibits proteolytic activity based on residues homologous to the HCV NS2 catalytic triad ( Fig. 1 ), we designed Identical, highly similar, and similar residues at each position of GBV-B and HCV NS2 proteins are indicated with asterisks, colons, and dots, respectively (similarity), according to Clustal W conventions. Gaps between GBV-B and HCV NS2 sequences are indicated by hyphens. The predicted secondary structure (Pred. Struct.) is indicated in italics above the GBV-B amino acid sequence (c, coiled; e, extended; h, ␣-helix; t, turn; ?, undefined). Residues exhibiting a propensity to partition into the lipid bilayer according to the interfacial hydrophobicity plot calculated with MPex are underlined. Predicted TM segments (consensus TM) are indicated as a succession of T's above the secondary-structure predictions. See Materials and Methods for details concerning the algorithms used for these predictions. The HCV NS2 secondary structure (Sec. Struct.) is depicted below the HCV JFH1 sequence. It was established based on the NMR structure of selected synthetic peptides representing TM segments of HCV 1b-Con1 NS2 (31, 34) as well as the crystal structure of the HCV 1a-H77 NS2 C-terminal subdomain (38) and membrane association properties of selected segments of this subdomain (67) . Solid and dotted boxes delineate hypothetical (GBV-B) or experimentally confirmed (HCV) TM and membrane-associated segments, respectively. Residues comprising the HCV NS2 protease catalytic triad are boxed in gray, and these conserved residues are also highlighted in the GBV-B NS2 sequence. Selected segments of GBV-B NS2 (S1 to S7) that were fused to GFP in this study are schematically represented by shaded boxes above the GBV-B sequence, with the positions of amino acid boundaries indicated at both extremities.
plasmids that allowed the transient expression of NS2-NS3 precursors from a cytomegalovirus (CMV) promoter. Plasmid DNAs ensured the expression of wild-type (wt) GBV-B or HCV NS2-NS3 precursors (NS2-3pro-ST) spanning the 208 or 217 aa of NS2 fused to the N-terminal 180 or 213 aa of NS3 that contain the NS3-4A serine protease domains of GBV-B and HCV JFH1, respectively, in which the catalytic Ser 139 residues were mutated into Ala residues. These polypeptide precursors were expressed downstream of the CD5 signal peptide to mimic ER translocation of the NS2 N terminus and were fused at their C termini to a twin Strep-tag (ST) for identification purposes. Proteins extracted from transfected Cos-1 cells were separated by SDS-PAGE, and ST-reactive products were detected by immunoblotting. As expected, the HCV JFH1 wt NS2-3pro-ST precursor was cleaved to completion at the NS2/NS3 junction to generate a 25-kDa product corresponding to NS3pro-ST (Fig. 2, right) . The mutation of the Cys residue of the HCV NS2 catalytic triad into an Ala residue (C184A) resulted in the detection of a 49-kDa product corresponding to the uncleaved precursor (Fig. 2, right) . These data showed that this approach was adapted to conclusively demonstrate NS2 proteolytic activity at the NS2/NS3 junction, as previously reported for HCV H77 NS2 in in vitro translation systems (36, 37) or in transient-expression systems in U-2OS or BHK21 cells (38, 66) . A product that migrated slightly faster than the full-length precursor was also detected in the case of the mutated HCV catalytic triad (Fig. 2, right) . It is compatible with posttranslational cleavage by an unidentified protease acting at a cryptic site located within the NS2 N-terminal TM segment, as previously reported (31) .
Similarly, upon expression of the GBV-B wt NS2-3pro-ST precursor, a 23-kDa product was detected, which likely corresponded to NS3pro-ST (Fig. 2, left) . This strongly suggested that cleavage also occurred in the GBV-B NS2-3pro-ST precursor at the NS2/ NS3 junction. The contribution of GBV-B NS3 protease to this cleavage event could be ruled out thanks to the mutation of its catalytic Ser residue. In addition, this cleavage was abrogated when the Cys residue of the putative catalytic site of GBV-B NS2 was mutated into an Ala residue (C177A), leading to the detection of a product with a molecular mass compatible with that of the full-length NS2-3pro-ST precursor (Fig. 2) . This demonstrated that GBV-B NS2, like HCV NS2, contains cysteine protease activity with C177 as a catalytic residue.
To experimentally confirm the predicted GBV-B NS2/NS3 junction, a pCMV-derived plasmid DNA containing GBV-B NS2-3pro-ST codon-optimized sequences was transfected into HEK 293T cells. This permitted the expression of high levels of the GBV-B NS2-3pro-ST polypeptide, which was subsequently cleaved by NS2 protease to give rise to NS3pro-ST, as observed for Cos-1 cells (data not shown). Proteins extracted from transfected cells were affinity purified by using Strep-Tactin beads and separated by SDS-PAGE, and the cleaved NS3pro-ST product was gel extracted and submitted for analysis on a matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometer following trypsin digestion. The analysis of trypsincleaved peptides confirmed the location of the NS2/NS3 junction between the Thr and Ala amino acids at positions 940 and 941 of the polyprotein (data not shown), hence providing an experimental demonstration that GBV-B NS2 comprises 208 aa corresponding to residues 733 to 940 of the viral polyprotein.
Analysis of membrane association properties of GBV-B NS2 segments. According to computer-aided secondary-structure predictions ( Fig. 1) , we defined a first set of six 32-to 96-aa-long sequences that spanned one or several of the five segments with putative membrane association properties within the N-terminal two-thirds of GBV-B NS2 (Fig. 3A , top, black segments). To determine the capacity of these segments as well as of full-length NS2 to associate with membranes, we generated pCMV-derived plasmids allowing the expression of GBV-B NS2 segments fused to green fluorescent protein (GFP). Following transient expression in Cos-1 cells, the subcellular localization of these fusion proteins was determined by fluorescence microscopy. While native GFP was diffusely distributed within the cell cytosol and nucleus (Fig.  3B) , the fusion of GBV-B NS2 segments or of full-length NS2 to GFP led to the relocalization of the GFP fluorescence to intracellular membranous compartments (data not shown). These results confirmed the membrane association of the GBV-B NS2 N-terminal segment spanning aa 1 to 141 and revealed the presence therein of at least two membranotropic sequences comprised of aa 32 to 67 and 110 to 141, respectively.
Based on the boundaries of this first set of segments, we next designed a second set of 6 contiguous, 17-to 33-aa-long segments, designated S1 to S6 ( Fig. 1 and 3A , bottom, blue segments), that spanned GBV-B NS2 aa 1 to 141 and contained either a computerpredicted TM segment (S1, S4, and S6), a segment with putative peripheral membrane association (MA) properties (S2 and S5), or presumably no membrane-associated segment (S3). A seventh segment (S7) spanned the C-terminal subdomain of GBV-B NS2 that harbors the proteolytic activity (aa 132 to 208). Plasmids allowing the expression of recombinant proteins comprised of each GBV-B NS2 segment fused to GFP were generated, and the integrity of all fusion proteins expressed in Cos-1 cells was verified by immunodetection with anti-GFP antibodies (Fig. 4) . The subcellular localization of the fusion proteins was determined by both direct fluorescence microscopy as well as colocalization with ERor Golgi apparatus-resident proteins (p63 and GM130, respectively). A known membrane-spanning segment comprising NS2 aa 27 to 59 (TM2 segment) of the Con1 strain of HCV genotype 1b (34) was used as a control to demonstrate the relocalization of the fused GFP fluorescence to the ER compartment in these cells (Fig.  3C) . Among GBV-B NS2 segments, three segments showed diffuse fluorescence (S3, S5, and S7) (Fig. 3D) , like GFP (Fig. 3B) ; three other segments showed fluorescence confined predominantly to the Golgi apparatus (S2, S4, and S6) (Fig. 3D) ; and one segment showed ER-confined fluorescence (SP-S1) (Fig. 3D) . The S1-GFP fusion protein was expressed downstream of the signal peptide of the cellular protein CD5 to mimic the predicted translocation of the GBV-B NS2 N terminus into the ER lumen. In the context of the native polyprotein, this translocation occurs via a association properties of GBV-B NS2 segments expressed as a fusion with GFP. The series of GBV-B NS2 segments expressed as a C-terminal fusion with a Gly-Ser (G-S) linker and GFP, as depicted at the top, are represented in the blow-up scheme by horizontal lines spanning the corresponding NS2 sequence, with amino acid boundaries (numbering refers to the amino acid position in NS2) indicated at both extremities. S1-GFP was expressed downstream of a heterologous signal peptide (sp) derived from the cellular protein CD5. Putative TM and membrane-associated (MA) segments are depicted as dark and light gray boxes, respectively, with amino acid boundaries indicated at the top. Membrane association (ϩ) or a lack of membrane association (Ϫ) properties, determined primarily by immunofluorescence patterns in transiently transfected cells (panel D and data not shown), are indicated at the right of each segment. S1 to S7 (in blue) were studied further. (B to D) Subcellular localization of NS2 segments fused to GFP in transiently transfected cells. Cells were transiently transfected with plasmid DNAs ensuring the expression of GFP (pCMV/GFP) (B) or fusion proteins comprised of GFP C-terminally fused to aa 27 to 59 of HCV Con1 NS2 (pCMVNS227-59-GFP DNA) (C) or fused to GBV-B NS2 sp-S1 and S2 to S7, as indicated above the images (pCMV/SX-GFP) (D). Forty hours later, cells were fixed and stained for ER (p63) or Golgi (GM130) compartments, as indicated at the top left corner of the images, for indirect immunofluorescence analysis. Cell nuclei were counterstained with DAPI. Cells were observed by using an Observer Z1 inverted fluorescence microscope (Zeiss) in the ApoTome mode using a 40ϫ objective. Representative images showing autofluorescent GFP (green), ER or Golgi compartments (red), and cell nuclei (blue) are superimposed. Bar, 20 m.
signal peptide located at the C terminus of p13. Of note, the expression of S1-GFP in the absence of any signal peptide presented a diffuse distribution within transfected cells (data not shown). This could be due to the fact that the N-terminal 32 residues of GBV-B NS2 do not exhibit intrinsic properties to associate with the lipid bilayer in the absence of addressing to the ER membrane translocation machinery.
Next, to confirm the data obtained by fluorescence microscopy, the membrane association properties of the seven GBV-B NS2 segments (S1 to S7) were examined on the basis of flotation of the corresponding GFP fusion proteins in density gradients. For this purpose, transfected cells were lysed by Dounce homogenization in hypotonic buffer and placed below discontinuous 54 to 0% sucrose gradients that were subsequently ultracentrifuged to equilibrium prior to the collection of the seven fractions. An ER-resident TM protein, p63, was used as a control for membrane flotation in all gradients. As shown by immunodetection of each fraction with anti-p63 antibodies (Fig. 4, top gels) , p63 was found in low-density gradient fractions (fractions 2 and 3) in all cases. It should be noted that a proportion of p63 remained in high-density fractions (fractions 6 and 7), maybe as a result of partial membrane fragmentation upon Dounce homogenization. In contrast to p63, native GFP was detected only in high-density fractions, corroborating the absence of a membrane association for this protein (Fig. 4A, bottom) . In addition, we verified that the expression of GFP downstream of the CD5 signal peptide did not alter its diffuse localization, regardless of whether or not the signal peptide was cleaved from GFP (Fig. 4A, middle) . In contrast, GFP fused to a known TM segment comprising aa 1 to 27 of the Con1 strain of HCV genotype 1b was detected in light fractions (Fig. 4B) , confirming that membrane associations of ectopically expressed proteins are efficiently detected by this method, as previously reported for Nycodenz gradients (59) . GFP fusion downstream of sp-S1, S2, S4, and S6 (Fig. 4C, D, F , and H, respectively) resulted in proteins that tightly interacted with membranes and floated. In contrast, S5-GFP and S7-GFP ( Fig. 4G and I, respectively) were or fusion proteins comprised of GFP C-terminally fused to aa 1 to 27 of HCV Con1 NS2 (pCMVNS21-27-GFP DNA) (B) or fused to the indicated segment (sp-S1 and S2 to S7) of GBV-B NS2 (pCMV/SX-GFP) (C to I). In panel D, extracts from S2-GFP-expressing cells were also treated with Triton X-100 (ϩ Triton X-100) (bottom gel) prior to loading below sucrose gradients. Seven fractions (fractions 1 to 7) were collected from the top of the density gradients following equilibrium ultracentrifugation, and the triangles at the bottom of the panels indicate the percent sucrose density gradient. The ER-resident p63 and GFP fusion protein contents of each fraction were determined following SDS-PAGE separation and immunodetection with the corresponding antibodies, as shown in the top and bottom gels, respectively. Cellular p63, GFP, GFP fused to the CD5 signal peptide (sp-GFP), GBV-B S1-GFP fused to the CD5 signal peptide (sp-S1-GFP), HCV fusion protein [(1-27)-GFP], GBV-B SX-GFP fusion proteins (S1-GFP to S7-GFP), as well as truncated (t) forms of these fusion proteins are identified at the right. Molecular weight markers (in thousands) are indicated at the left.
found almost exclusively in dense fractions, confirming the absence of a membrane association of these two segments. The density pattern observed for the S3-GFP fusion revealed its predominant association with dense fractions (Fig. 4E ), in agreement with its diffuse distribution within the cell cytoplasm (Fig. 3D) . A minor fraction of S3-GFP was found in low-density fractions, which may be explained by the propensity of this NS2 segment to partition into an apolar environment, as suggested by interfacial hydrophobicity predictions (Fig. 1) . Moreover, the alternation of hydrophobic and negatively charged residues, together with the presence of several Phe residues in the S3 sequence, may be indicative of an amphipathic helix that might insert in-plane at the membrane interface.
Comparative analysis of transmembrane properties and orientation of GBV-B and HCV NS2 segments. In order to determine whether GBV-B NS2 S1, S2, S4, and S6, shown to interact with intracellular membranes (Fig. 3D and 4) , were able to span the lipid bilayer, we used an N-glycosylation scanning approach. This approach was also applied to HCV Con1 NS2 with the objective to ascertain the HCV NS2 topology model initially based on the membrane association properties of isolated NS2 segments (34) . A sequence containing an Asn-Ser-Thr (NST) N-glycosylation acceptor site flanked by 12-aa linkers was inserted on both sides of each potential TM segment within GBV-B and HCV NS2. We generated a series of pCMV-derived plasmids that allowed the transient expression downstream of the CD5 signal peptide of NS2 residues 1 to 145 from HCV Con1 or residues 1 to 141 from GBV-B that contained a unique NST sequence and was C-terminally fused to GFP. Since the addition of oligosaccharides to NST acceptor sites occurs specifically in the ER lumen, the determination of the glycosylation status of each NS2 protein containing a unique NST sequence was expected to provide information on the global topology of full-length NS2 with respect to the ER membrane.
We first confirmed by fluorescence microscopy that the insertion of an NST sequence in all fusion proteins did not alter their ER association in transfected Cos-1 cells (data not shown). Proteins extracted from transfected cells were separated by SDS-PAGE, and GFP-reactive products were detected by immunoblotting. Additional products harboring an ϳ2.5-kDa shift in molecular mass were detected in the case of glycosylation acceptor tag insertions at the N terminus as well as downstream of residues 70 and 67 of HCV and GBV-B NS2 proteins, respectively ( Fig. 5A and B, lanes 1 and 7, asterisks) . These additional products were abrogated by incubation of the cellular extracts with peptide-N-glycosidase F (PNGase F) prior to SDS-PAGE ( Fig. 5A and B,  lanes 2 and 8) , showing that the increase in molecular mass resulted from the addition of N-linked oligosaccharides. Moreover, glycosylation was abolished when the Asn residue within the Nglycosylation acceptor site was mutated to a Gln residue (Fig. 5A,  lanes 3 and 4, and B, lanes 3, 4, 9 , and 10), confirming that the inserted sequence was specifically glycosylated. It should be noted that glycosylation remained incomplete at all ER lumen-facing sites, possibly as a result of steric hindrance, only partial accessibility of the acceptor sequence to the glycosylation complex, and/or saturation of the glycosylation machinery. The lack of glycosylation of sequences inserted downstream of residues at positions 27, 99, and 145 of HCV NS2 or at positions 31, 96, and 141 of GBV-B NS2 indicates that these residues are likely located at the cytoplasmic face of the ER membrane ( Fig. 5A and B, lanes 5, 6,  and 11 to 14) . Furthermore, GBV-B proteins bearing two N-glycosylation tags either at the N terminus and downstream of aa 31 or at the N terminus and downstream of aa 67 were glycosylated at only one or both inserted sites, respectively (data not shown). This indicated that the length of the inserted sequences did not alter the NS2 topology and confirmed data obtained for proteins bearing the single respective insertions. Altogether, data from this analysis of the luminal versus cytosolic localization of inserted NST sequences strongly suggest that GBV-B NS2 S1, S2, and S4 span the lipid bilayer but that S6 does not. Importantly, glycosylation data obtained here for HCV Con1 NS2 are in full agreement with the previously proposed topological model (34) and support the presence of three TM segments in the N-terminal region of NS2 from both GBV-B and HCV (see Fig. 8 ).
Experimental structural analyses of GBV-B NS2 S1, S2, and S6 and deduced membrane topology model for GBV-B NS2. To gain further insight into the structure and membranotropic properties of S1, S2, and S6, the corresponding peptides, designated GBV-B NS2(2-32), NS2 , and NS2(113-137), respectively, were chemically synthesized and purified to homogeneity, and their structures were analyzed by CD and NMR spectroscopy in membrane-mimetic environments. Attempts to chemically synthesize a peptide corresponding to membrane-associated S4 (aa 67 to 96) failed, likely due to the presence of three cysteine residues in its sequence.
The CD spectra of the NS2(2-32), NS2 , and NS2(113-137) peptides in water indicate limited folding, with the presence of some poorly defined secondary structures (Fig. 6A to C, left) . However, solubilization of the NS2(2-32) and NS2(113-137) peptides in membrane-mimetic medium including a lysophos-
, and sodium dodecyl sulfate [SDS]), or a 2,2,2-trifluoroethanol (TFE)-water mixture resulted in spectra typical of ␣-helical folding, with two minima at 208 and 222 nm and a maximum at 192 nm. The NS2(32-57) peptide also exhibits a tendency to fold into an ␣-helix, at least in LPC, DPC, and DDM, but the aromatic rings of the four Trp residues in this peptide are expected to seriously interfere with the far-UV CD signal and thus prevent accurate spectrum interpretations.
Peptide samples prepared in deuterated SDS or DPC micelles displayed broad, poorly resolved NMR spectra, likely due to the micelle sizes. Therefore, the NMR structures of these peptides were studied in 50% TFE-d 2 , which yielded well-resolved homoand heteronuclear multidimensional spectra (data not shown). The sequential attribution of all spin systems was complete, and an overview of the sequential and medium-range NOE connectivities is shown in Fig. 6 (right) . The patterns of NOE connectivities clearly demonstrate that the main body of these peptides displays most characteristics of ␣-helices, including strong dNN(i, i ϩ 1) and medium d␣N(i, i ϩ 1) sequential connectivities as well as weak d␣N(i, i ϩ 2), medium or strong d␣N(i, i ϩ 3) and d␣␤(i, i ϩ 3), and weak d␣N(i, i ϩ 4) medium-range connectivities. The NOE-based indications of ␣-helical conformation were also supported by the deviation of the 1 H ␣ and 13 C ␣ chemical shifts from random-coil values (data not shown). Based on the NOE-derived interproton distances, sets of 50 structures were calculated with X-plor, and final sets of 39, 36, and 28 low-energy structures that fully satisfied the experimental NMR data were retained for NS2(2-32), NS2 , and NS2(113-137), respectively. The remarkable structural features of the three GBV-B NS2 peptides are illustrated in the representative three-dimensional models shown in Fig. 7 . The relatively short helix (aa 13 to 29) of the NS2(2-32) peptide is globally hydrophobic but exhibits a more polar side including small polar residues (Fig. 7A) , suggesting that it is likely involved in intra-and/or intermolecular interactions with other TM segments. The presence of some large hydrophobic residues in its polar, unstructured, N-terminal segment (aa 5 to 12) suggests that this region could also be involved in interactions with other membrane-associated segments in the protein context. Overall, the physicochemical and structural features of this peptide are reminiscent of those observed for the N-terminal TM segment of HCV NS2 (31) .
The long helix (aa 34 to 54) observed for the GBV-B NS2(32-57) peptide (Fig. 7B) clearly exhibits an amphipathic character, with numerous polar and charged residues located on one helix side, while the hydrophobic side includes bulky hydrophobic aromatic residues, notably an unusually large number of Trp residues (four). These features suggest that this amphipathic helix might interact with the membrane interface in an in-plane topology, at least transiently. Based on physicochemical considerations, a TM orientation of such an amphipathic ␣-helix could be achieved only upon an interaction with another complementary TM segment neutralizing the polar and charged residues located in the hydrophobic core of the membrane. The overall structural features of this peptide are reminiscent of those observed for the second TM segment of HCV NS2 (34) .
In the case of the GBV-B NS2(113-137) peptide, the hydrophobic helix at residues 116 to 135 includes a short stretch of polar and negatively charged amino acids (GENG; aa 129 to 132), which is likely flexible because of the presence of two glycine residues (Fig. 7C) . The overall hydrophobic nature of this helix likely explains its prediction as a TM segment (Fig. 1) . However, the hydrophobicity together with the dispersion of charged residues in this peptide are compatible with its location in the NS2 cytosolic domain (Fig. 5B ), in interaction with the membrane interface (S6) (Fig. 3D and 4H) .
The relatively high amino acid sequence similarities between the C-terminal cytosolic domain of GBV-B NS2 and that of HCV NS2 allowed us to construct a three-dimensional homology model for this region (Fig. 8A) , using the crystal structure of HCV NS2 as the template (38) . Remarkably, the ␣-helix at residues 116 to 135 revealed in the NS2(113-137) peptide by NMR (Fig. 7C ) fits with that observed in this homology model (helix 2 [H2]) (Fig.  8A, dark pink cylinder) . This helix has a counterpart in HCV NS2 (H2; aa 123 to 136) (Fig. 8B , dark blue cylinder), which has also been shown to associate with membranes (67) .
Altogether, three-dimensional structural findings for the three GBV-B NS2 peptides analyzed (Fig. 7 ) are in agreement with data concerning NS2 segment orientation with respect to ER membranes (Fig. 5B ). All experimental findings described in this study concurred to demonstrate the existence of three TM segments in the N-terminal regions of both HCV and GBV-B NS2, revealing that these two proteins share common topological organizations in spite of limited sequence similarity, as modeled in Fig. 8 .
Role of NS2 in morphogenesis is virus and genotype specific. The lack of a GBV-B reverse-genetics system has precluded direct investigations of a potential involvement of NS2 in GBV-B particle morphogenesis and/or egress, while HCV NS2 was shown to play a crucial role during these steps of the viral cycle (reviewed in reference 42). Since GBV-B and HCV NS2 proteins share similar topological organizations and proteolytic activities, we investigated whether GBV-B NS2 was able to functionally substitute for HCV NS2 in viral morphogenesis. A first approach based on HCV JFH1/GBV-B chimeras encoding part or all of the GBV-B p13-NS2 sequences in place of the corresponding HCV p7-NS2 sequences failed to give rise to cell culture-adapted viruses (data not shown). Toward using a trans-complementation approach, we generated a genome-length HCV cDNA (Jad/S168E) encoding an assembly-deficient mutation within NS2 and derived from a JFH1 variant (Jad) of HCV genotype 2a, which contains highly cell culture-adaptive mutations in NS5A and NS5B (51) . The inactivating S168E substitution in NS2 was chosen since it targets the NS2 protease cytosolic domain and was previously shown to lead to a severe defect in virion morphogenesis in the Jc1 backbone without altering genome replication (68) . Similar levels of core and NS2 were detected in Huh-7.5 cells transfected with in vitro-transcribed parental Jad or mutant Jad/S168E RNAs (Fig. 9A, top and  bottom, lanes 2 and 3) , indicating that the Jad/S168E RNA was fully replicative and that the S168E substitution did not alter NS2 stability or cleavage efficiency at the NS2/NS3 junction. TCID 50 titration of supernatants from Huh-7.5 cells transfected with the parental Jad RNA or with the mutated Jad/S168E RNA showed that the NS2 S168E mutation completely abrogated infectiousvirus production in this context (Fig. 9B) . To investigate the impact of NS2 genetic distance on transcomplementation of Jad/S168E, we studied whether the Jad/ S168E mutant could be rescued by the expression in trans of NS2 not only from GBV-B but also from HCV strains of the same genotype (genotype 2a) or another genotype (genotype 1b). We thus generated four helper RNAs encoding homologous NS2 from HCV JFH1 or heterologous NS2 from either the J6 strain of HCV genotype 2a, the N strain of HCV genotype 1b, or GBV-B downstream of their respective signal peptides located at the p7 or p13 C terminus within the backbone of a previously described bicistronic, subgenomic JFH1 replicon (31) . These heterologous proteins share 87% (99%), 57% (85%), and 21% (54%) amino acid identities (amino acid similarities) with JFH1 NS2, respectively. In order to be able to compare the intracellular levels of these NS2 proteins expressed in trans, we introduced a V5 epitope downstream of the NS2 N-terminal residue, which was previously shown to have no effect on particle assembly within the JFH1 backbone (data not shown).
In Huh-7.5 cells cotransfected with the Jad/S168E assemblydeficient RNA and subgenomic helper RNAs, V5-NS2 proteins expressed from JFH1, J6, N, and GBV-B NS2 helper RNAs were detected at similar levels by immunoblotting with anti-V5 antibodies (Fig. 9A, middle, lanes 4 to 7) . This indicated that all helper RNAs replicated efficiently and that V5-NS2 proteins provided in trans were stable, warranting the use of these RNAs in rescue experiments.
Although NS2-S168E and V5-NS2 proteins were both detected in cotransfected cells (Fig. 9A, bottom, lanes 4 and 5) , de- , and NS2(113-137) (C) peptides. The amino acid sequences of the corresponding peptides are depicted at the top of each panel, and boxes indicate ␣-helix residues. Based on the NOE-derived interproton distances reported in Fig. 6 , sets of 50 structures were calculated with X-plor, and final sets of 39, 36, and 28 low-energy structures that fully satisfied the experimental NMR data were retained for NS2(2-32), NS2 , and NS2(113-137) peptides, respectively. Superimpositions of each set of structures (data not shown) highlight the most wellorganized helical part for each peptide, i.e., segments spanning residues 13 to 28, 37 to 51, and 118 to 132, exhibiting RMSDs of 0.97, 0.63, and 0.71 Å for the backbone atoms (C=, C ␣ , and N) for NS2(2-32), NS2 , and NS2(113-137) peptides, respectively. Representative NMR structures of each peptide (PDB accession numbers 2LZP [A], 2LZQ [B] , and 2MKB [C]) are shown as ribbon-and-stick models, and the molecular surface of helices highlighting their hydrophilic and hydrophobic sides is shown in the middle and left views. The corresponding helix projections are shown on the right. Residues are color coded according to Wimley-White hydrophobicity scales (55), as follows: hydrophobic residues are gray; Phe and Trp are black; the polar residues Gly, Ala, Ser, Thr, Asn, and Gln are yellow; positively and negatively charged groups of basic and acidic residues are blue and red, respectively; and His is cyan. Figures were generated from structure coordinates by using VMD (http://www.ks.uiuc.edu/Research/vmd/) and rendered with POV-Ray (http://www.povray.org/). creases in core and NS2 protein levels expressed from the genomic Jad/S168E RNA were observed, compared to protein levels in cells transfected with Jad/S168E RNA alone (Fig. 9A , top and bottom, compare lanes 4 to 7 to lane 3). Furthermore, Jad infectious titers were ϳ0.5 logs lower in cells cotransfected with NS2 helper RNAs than in cells transfected with Jad alone (Fig. 9B ). This could be due to the cytotoxicity of the helper RNA and/or to competition between the two transfected RNAs, as previously described (31) .
The trans-complementation efficiency was determined by TCID 50 titration of cell supernatants collected at 48 h posttransfection. Expression of homologous JFH1 V5-NS2 in trans led to a partial rescue of infectious Jad/S168E particle production in cotransfected cells (Fig. 9B) , confirming that the function of NS2 in particle assembly could be reliably complemented in trans, as previously reported (31, 69) . V5-NS2 from the J6 isolate of HCV genotype 2a was able to trans-complement the Jad/S168E defect to the same degree as homologous JFH1 NS2 (Fig. 9B) . In contrast, neither NS2 from the N isolate of HCV genotype 1b nor GBV-B NS2 could rescue the Jad/S168E assembly defect. These results indicate that the role of NS2 in particle morphogenesis is virus and genotype specific but is not strain dependent.
Analysis of the trans-complementation activities of chimeric NS2 proteins. Residues from both the membrane N-terminal and cytosolic C-terminal NS2 domains have been involved in HCV particle assembly (34, 68) . Our goal here was to investigate whether the two domains could be functionally uncoupled in this process. Based on the common TM1-2-3 segment organization of GBV-B and HCV NS2 N-terminal domains and the shared presence of one membrane-interface-associated helix in the cytosolic NS2 domains (Fig. 8) , we generated chimeric GBV-B/JFH1 NS2 proteins in which part or all of the N-terminal TM anchors and cytosolic membrane-interacting helices were replaced by equivalent structural segments from GBV-B NS2. We then assessed their ability to trans-complement the assembly defect of Jad/S168E NS2, which mapped to the NS2 C-terminal region. Corresponding helper RNAs were generated, in which chimeric NS2 coding sequences were inserted downstream of JFH1 sequences encoding the last C-terminal residues of E1 acting as a signal peptide followed by E2-p7, so as to express NS2 from E2-p7-NS2 precursors properly translocated into the ER lumen. Previous studies indeed suggested that E2-p7-NS2 performed better than NS2 in trans-complementation studies (31) . All chimeric intra-and intergenotypic HCV NS2 proteins were stably expressed, as shown by immunoblotting using antibodies directed against the JFH1 NS2 cytosolic domain (Fig. 10A) . In contrast, among GBV-B/JFH1 chimeric NS2 proteins, only that bearing the smallest substitution, TM (1) GB NS2, was stable ( Fig. 10A and data not shown). This suggested that the genetic distance between Fig. 7 . TM3, for which no NMR structure is available, is represented by an orange cylinder. The three TM segments are tentatively positioned as separate entities in the membrane, and the boundaries of TM ␣-helices are indicated on each side of the helices. Connecting sequences between TM segments are tentatively represented within membrane interfaces by dotted lines. The C-terminal cytosolic domain of GBV-B NS2 is represented by a three-dimensional homology model of one dimer subunit constructed by using the crystal structure of the HCV NS2 cytosolic domain as the template (PDB accession number 2HD0) (38) and the Swiss-Model automated protein structure homology modeling server (http://www .expasy.org/spdbv/). The resulting tentative model includes an ␣-helix spanning residues 116 to 135 (H2) with demonstrated membrane association properties, schematized as a dark pink cylinder within the plane of the membrane. (B) The HCV NS2 membrane topology model relies on the NMR structure of peptides representing the three N-terminal TM segments (31, 34) confirmed by the determination of the TM segment orientation with respect to the ER membrane (this study), the three-dimensional crystallographic structure of one dimer subunit of the C-terminal cytosolic domain (38) , and the membrane association of this domain via ␣-helices H1 and H2 (67) .
GBV-B and HCV JFH1 precluded the folding and/or the stability of chimeric NS2 comprising an N-terminal GBV-B membrane anchor and a C-terminal JFH1 cytosolic domain. In cells cotransfected with the assembly-deficient Jad/S168E genomic RNA and each E2-p7-NS2 helper RNA, Jad/S168E RNA replicated efficiently, as documented by the even production of core (Fig. 10B) . TM (1) GB NS2, like TM(1) N NS2, was unable to trans-complement the assembly defect of Jad/S168E (Fig. 10C ), while TM (1) J6 efficiently rescued Jad/S168E virus production to a level ϳ1.5 logs lower than that of parental Jad (Fig. 10C) . Likewise, only intragenotypic chimeric TM(123) J6 and TM(123)-MA J6 NS2 proteins were able to trans-complement Jad/S168E assembly, like native JFH1 NS2 (Fig. 10C) . Of note, TM(123)-MA J6 NS2 acted with a ϳ1-log-lower efficiency than that of TM (123) J6 NS2 (Fig. 10C ), although they were expressed at similar levels (Fig. 10A) , highlighting the role of membrane-interface-associated segments within the cytosolic domain of NS2 in JFH1 morphogenesis. In contrast, cotransfection with intergenotypic TM(123) N or TM(123)-MA N helper RNAs did not lead to virus production. These results highlight a genotype-specific, intramolecular concerted action between TM(1) and the other N-terminal TM segments and/or between the N-terminal TM region and the Cterminal protease domain of HCV NS2 during virion morphogenesis. Proteins were extracted at 48 h posttransfection from cells transfected in the absence of RNA (mock), transfected with cell culture-adapted Jad genomic RNA or with Jad/S168E genomic RNA encoding the S168E substitution within NS2, or cotransfected with Jad/S168E RNA and subgenomic V5-NS2 helper RNAs (in boldface type) expressing NS2 proteins from the indicated HCV strains (JFH1, J6, and N) or from GBV-B (GB), which were N-terminally tagged with a V5 epitope. Proteins were separated by SDS-PAGE and analyzed with antibodies specific for JFH1 core (top), V5 (middle), or JFH1 NS2 (bottom). Molecular weight markers (in thousands) are indicated at the left. Note that NS2 expressed by Jad/S168E genomic RNA (NS2 JFH1 ) is distinguishable from NS2 expressed by the subgenomic helper RNA that is fused to the V5 tag (V5-NS2 JFH1/J6 ), therefore migrating with a higher apparent molecular mass. Also note that NS2 antibodies recognize only HCV genotype 2a (JFH1 and J6) NS2 proteins. (B) Infectivity rescue. Huh-7.5 cells were cotransfected with either Jad (gray bars) or Jad/S168E (black bars) genomic RNA and the indicated V5-NS2 helper RNAs (HCV genotypes are shown in parentheses) or transfected with genomic RNAs in the absence of helper RNA (Ϫ). Release of infectious viral particles was determined at 48 h posttransfection by TCID 50 titration of transfected-cell supernatants in Huh-7.5 cells. Means and standard deviations of Ն3 independent transfections are shown. Proteins extracted from cells transfected in the absence of RNA (mock), transfected with Jad or Jad/S168E genomic RNAs, or cotransfected with Jad/S168E RNA and the indicated helper RNAs (in boldface type) were separated by SDS-PAGE and analyzed with antibodies specific for core. (C) Infectivity rescue. Huh-7.5 cells were cotransfected with either parental Jad (gray bars) or assembly-deficient Jad/S168E (black bars) genomic RNAs and no helper RNA (Ϫ) or subgenomic helper replicons encoding E2-p7-NS2 precursors which comprise JFH1 NS2 or the indicated chimeric NS2s. These are described above for panel A and are schematically represented at the bottom with JFH1 and heterologous sequences depicted by gray and black boxes, respectively. Release of infectious viral particles was determined at 48 h posttransfection by TCID 50 titration of transfected-cell supernatants in Huh-7.5 cells. Means and standard deviations of Ն2 independent transfections are shown.
DISCUSSION
In recent years, genetic and protein-protein interaction studies have revealed that membrane-associated NS2 is a key organizer of HCV morphogenesis (34, 35, (43) (44) (45) . However, the exact mechanism of action of NS2 during infectious-particle assembly and possibly egress remains undetermined. NMR studies of short segments of its hydrophobic N-terminal region previously ascertained the TM anchoring of NS2 from the Con1 strain of HCV genotype 1b (31, 34) . The identification of the ER lumen versus the cytosolic localization of NS2 sequences following the insertion of N-glycosylation acceptor sites shown here (Fig. 5 and 8 ) fully supports the previously proposed model for HCV NS2 membrane topology (34) . Furthermore, the three approaches that were used here to determine the topological organization of NS2 from a distantly related hepacivirus, small New World primate GBV-B, all concurred to show that GBV-B NS2 also contains three membrane-spanning segments in its N-terminal region and at least one segment peripherally associated with membranes in its C-terminal region. Experimental approaches included (i) the determination of the membrane association properties of NS2 segments by both fluorescence microscopy ( Fig. 3 ) and flotation gradients (Fig.  4) , (ii) the identification of the topological orientation of NS2 sequences with respect to the ER membrane following the insertion of N-glycosylation acceptor sites (Fig. 5) , and (iii) resolution of the NMR structures of selected NS2 peptides identified as being membrane-associated segments ( Fig. 6 and 7) . Therefore, these results revealed that, in spite of only limited amino acid sequence similarities with the homologous HCV protein (in the amino acid identity and similarity ranges of ϳ20% and ϳ50%, respectively), GBV-B NS2 remarkably shares a similar membrane topology with HCV NS2. Interestingly, the NMR structure of the TM2 segment from both HCV NS2 (34) and GBV-B NS2 (Fig. 7B) revealed similar atypical membranous ␣-helices comprised of numerous polar and charged residues located on one helix side, suggesting that the membrane insertion of these segments is likely to be mediated through interactions with complementary ␣-helices. Although genetic studies were not possible for GBV-B given the lack of a reverse-genetics system for this virus, in the case of HCV, direct or indirect interactions of NS2 TM2 with NS2 TM1 and with the N-terminal TM segment of the upstream p7 protein have been documented by genetic analyses (34) and NMR studies (70) . NMR studies of the GBV-B NS2(2-32) peptide indicated that the TM1 ␣-helix extends from aa 12 to 31, while its N terminus is essentially disordered (Fig. 6A and 7A ). Although this ␣-helix does not fully align with HCV TM1, which extends from aa 2 to 24 and includes a helix-breaking Gly residue at position 10 (31), the overall structures of both TM1s appear similar. Together, these results suggest that, in spite of minor ␣-helix TM differences, the membrane topology summarized in Fig. 8 for GBV-B and HCV is likely to also be shared by NS2 proteins from new members of the Hepacivirus genus that are phylogenetically either closer to HCV (e.g., equine hepaciviruses [8, 11] ) or closer to GBV-B (e.g., rodent, bat, and Old World monkey hepaciviruses [11, 13, 14] ) (Fig.  11A) . Indeed, although the amino acid sequences in the NS2 membrane binding domain appear to be species specific, with the exception of some patches of well-conserved residues (aa 28 to 47 and 65 to 69), the good conservation of the overall hydropathy profiles and of secondary-structure predictions suggests the conservation of TM segments across all hepacivirus NS2 proteins (Fig.  11B) .
We also showed that NS2 from GBV-B (Fig. 2) shares with HCV NS2 (36-38) a cysteine protease activity responsible for cleavage at the NS2/NS3 junction. In recently identified hepaciviruses, the catalytic-dyad residues (His and Cys) as well as the third negatively charged partner (Glu/Asp) and the adjacent cis-Pro residue are conserved (Fig. 11B) , suggesting that NS2 protease function is likely shared by different members of the Hepacivirus genus. Subcellular localization and flotation gradient analyses of NS2-GFP fusion proteins revealed that the C-terminal half of GBV-B NS2 contains one segment (S6) exhibiting a propensity to associate peripherally with membranes ( Fig. 3D and 4H ). This sequence was further identified by NMR studies as an ␣-helix spanning aa 116 to 135, which is mainly hydrophobic but also includes charged residues (Fig. 6C and 7C) . The equivalent ␣-helix revealed in the HCV NS2 crystal structure (H2; aa 123 to 136) (38) (Fig. 8B) was recently shown to also interact with the membrane interface, most likely together with the antiparallel ␣-helix H1 (aa 102 to 114) (Fig. 8B) , and to contain residues that are critical for NS2 stability and efficient polyprotein processing (67) . Similar helices are also predicted for NS2 proteins of recently identified hepaciviruses (Fig. 11B) . The conservation of such a membrane binding determinant across distantly related hepaciviruses is indicative of the importance of the membrane anchoring of the NS2 cytosolic domain for NS2 functions.
trans-complementation approaches revealed that an assembly defect due to a lethal substitution in the NS2 C-terminal domain (S168E) within the backbone of a highly cell culture-adapted virus derived from the JFH1 strain of HCV genotype 2a could not be complemented by NS2 from another hepacivirus (GBV-B) or a strain of another HCV genotype (genotype 1b) provided in trans by dicistronic subgenomic HCV replicons but could be rescued by NS2 from another strain of the same HCV genotype (Fig. 9) . These findings extend data from a previous report showing that NS2 of HCV genotype 1a expressed via an alphavirus replicon was not able to trans-complement an NS2 defect within the backbone of wild-type JFH1 (69) . This lack of intervirus and intergenotype cross-functionality may be explained by the disruption of NS2 interactions with E2, p7, and/or NS3 that have been shown to be involved in HCV morphogenesis by genetic and coimmunoprecipitation studies (34, 35, 44, 45) . In addition, we found that the defect of Jad/S168E could not be rescued by the expression in trans of chimeric NS2 comprised of the JFH1 C-terminal cytosolic domain containing the native S168 residue and various lengths of the N-terminal membrane-associated domain [TM(123)-MA, TM (123), and TM(1)] of HCV genotype 1b (Fig. 10C) , although the stability of these hybrid NS2 proteins (Fig. 10A) argues against a defect in their membrane insertion or subcellular localization. Besides, these chimeric NS2 proteins are all expected to be able to form homodimers with the NS2-S168E mutant, given that they share identical protease domains, which contain residues involved in NS2 homodimerization (38, 71) . Our data thus suggest that the N-terminal membrane anchor and C-terminal cytosolic domains of NS2 cannot be functionally uncoupled, underscoring the existence of important, genotype-specific intramolecular interactions between these domains during HCV morphogenesis. However, some degree of cross-genotype functionality was reported for genotype 1a, as shown by the rescue of JFH1-S168A mutant by chimeric helper NS2 comprising a 1a-H77 TM(123)-MA segment (69) . Our data are in line with a recent report showing direct or indirect interactions between the cytosolic loop joining TM1 and TM2 segments and the protease domain of NS2 that are critical for virus production (72) . It is interesting to note, however, that individual residues identified by de la Fuente and colleagues in these interactions (L30, R32, and Y39) (72) are conserved between HCV 2a-J6, 2a-JFH1, and 1b-N, suggesting that other determinants in this region are involved. The replacement of JFH1 NS2 TM1 or only the ␣-helix of TM1 by the corresponding HCV 1b-N segments ( Fig. 10 and data not shown) yielded stable hybrid proteins that did not provide functional trans-complementation. This result contrasts with the successful recovery, albeit with decreased titers, of a JFH1/1b-Con1 chimeric virus encoding a hybrid NS2 protein with the HCV 1b-Con1 TM1 ␣-helix sequence (34), again indicating some degree of intergenotypic cross talk depending on the system used. In comparison, the C-terminal membrane anchor of NS5B proved more permissive, since it could be replaced by the equivalent GBV-B sequence within the backbone of an HCV 1b-Con1 subgenomic replicon without abolishing replication activities (73) . Adaptive compensatory mutations within the mutant replicon RNA were, however, necessary to restore parentlike activity.
In conclusion, we showed that the NS2 membrane topology, with 3 TM segments in its N-terminal region and 1 or 2 membrane-associated segments in its C-terminal region, is a common organization of distantly related hepaciviruses, pointing to common functions of NS2 in the hepacivirus infectious life cycle. The genotype-specific, intramolecular interactions between N-and Cterminal domains of NS2 that are critical during viral particle assembly or release, but not for NS2 proteolytic activity, underscore the complex mode of action of this at least bifunctional protein. Further investigations are needed to determine how these homotypic NS2 interactions interconnect with known critical interactions of NS2 with other viral proteins and possibly host factors during the HCV life cycle.
